A Phase I, Open-Label, Randomized, Single-Center, 2-Stage Group Sequential Design, 2-Way Crossover Bioequivalence Study Comparing a Fixed-Dose Combination Capsule of Esomeprazole 40mg and Low-Dose Acetylsalicylic Acid [aspirin] (ASA) 325mg With a Free Combination of Esomeprazole Capsule 40mg and Low-Dose ASA
Phase of Trial: Phase I
Latest Information Update: 04 Jun 2009
At a glance
- Drugs Aspirin; Aspirin/esomeprazole; Esomeprazole
- Indications Cardiovascular disorders; Embolism and thrombosis; NSAID-induced gastrointestinal damage
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 04 Jun 2009 Results were reported at Digestive Disease Week 2009.
- 04 Jul 2008 New trial record.